The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats

Immunology

Volumn 98, Issue 2, 1999, Pages 267-272

  Zhang, L ^a   Mia, M Y ^a   Zheng, C L ^a   Hossain, M A ^a   Yamasaki, F ^a   Tokunaga, O ^a   Kohashi, O ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; DRUG VEHICLE; FREUND ADJUVANT; HEXADECANE; OLEIC ACID METHYL ESTER; PRISTANE; SQUALANE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HELPER CELL; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ADOPTIVE TRANSFER; ALKANES; ANIMALS; ARTHRITIS, EXPERIMENTAL; CONCANAVALIN A; FEMALE; FREUND'S ADJUVANT; LYMPHOCYTES; OLEIC ACIDS; RATS; RATS, INBRED LEW; SQUALENE; TERPENES; TH1 CELLS; TH2 CELLS; VEHICLES;

EID: 0032846064     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00854.x     Document Type: Article

References (31)

1. 1. PEARSON C.M. (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 91, 95.
2. 2. WHITTEHOUSE M.W., ORR K.J., BECK F.W.J. & PEARSON C.M. (1974) Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology 27, 311.
3. 3. KLEINAU S., ERLANDSSON H., HOLMDAHL R. & KLARESKOG L. (1991) Adjuvant oils induce arthritis in DA rat: I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 4, 871.
4. 4. VINGSBO C., SAHLSTRAND P., BRUN J.G. et al. (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibilily complex and non-major histocompatibility complex genes. Am J Pathol 149(5), 1675.
5. 5. POTTER M. & WAX J.S. (1981) Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol 127, 1591.
6. 6. CHANG Y.H., PEARSON C.M. & ABE C. (1980) Adjuvant poly-arthritis: IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies. Arthritis Rheum 23, 62.
7. 7. KLEINAU S. & KLARESKOG L. (1993) Oil-induced arthritis in DA rat. Passive transfer by T cells but not with serum. J Autoimmun 6, 449.
8. 8. TAUROG J.D., SANDBERG G.P. & MAHOWALD M.L. (1983) The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by Concanavalin A and by immunosuppressive pretreatment of the recipient. Cell Immunol 75, 271.
9. 9. TAUROG J.D., SANDBERG G.P. & MAHOWALD M.L. (1983) The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 80, 198.
10. 10. ROMAGNANI S. (1997) The Th1/Th2 paradigm. Immunol Today 18, 263.
11. 11. BACH J.F. (1996) Cytokine-based immunomodulation of autoimmune diseases: an overview. Transplant Proc 28(6), 3023.
12. 12. TRENTHAM D.E., TOWNES A.S. & KANG A.H. (1977) Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146, 857.
13. 13. KOHASHI O., AIHARA K., OZAWA A. et al. (1982) New model of synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine-induced arthritis. Clinical and histologic studies in athymic nude and cuthymic rats. Lab Invest 41, 27.
14. 14. KOHASHI O., PEARSON C.M., BECK F.J. & ALEXANDER M. (1977) Effect of oil composition on both adjuvant-induced arthritis and delayed hypersensitivity to purified protein derivative and peptidoglycans in various rat strains. Infect Immun 17(2), 244.
15. 15. CANNON G.W., WOODS M.L., CLAYTON F. & GRIFFITHS M.M. (1993) Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol 20, 7.
16. 16. LORENTZEN J.C., GLASER A., JACOBSSON L. et al. (1998) Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci USA 95, 6383.
17. 17. GASTON J.S.H. (1998) Role of T-cells in the development of arthritis. Clin Sci 95 (1), 19.
18. 18. VAN EDEN W., THOLE J.E.R., VAN DER ZEE R. et al. (1988) Cloning of the mycobacteria epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331, 171.
19. 19. HOLOSHITZ J., NAPARSTEK Y, BEN-NUN A. & COHEN I.R. (1983) Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219, 56.
20. 20. VAN EDEN W., HOLOSHITZ J., NEVO Z. et al. (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82, 5117.
21. 21. RÖCKEN M., RACKE M. & SHEVACH E.M. (1996) IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17, 225.
22. 22. OHTA Y., YAMANE M., SOHDA T. & MAKITO H. (1997) TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis. Immunology 92, 75.
23. 23. SVELANDER L., MÜSSENER Å., ERLANDSSON-HARRES H. & KLEINAU S. (1997) Polyclonal Th1 cells transfer oil-induced arthritis. Immunology 91, 260.
24. 24. ASHERSON L.G. (1966) Selective and specific inhibition of 24-hour skin reactions in the guinea-pig. II. the mechanism of immune deviation. Immunology 10, 179.
25. 25. CANNON G.W., GRIFFITHS M.M. & WOODS M.L. (1993) Suppression of adjuvant-induced arthritis in DA rats by incomplete Freund's adjuvant. Arthritis Rheum 36, 126.
26. 26. MIOSSEC P., CHOMARAT P. & DECHANET J. (1996) By passing the antigen to control rheumatoid arthritis. Immunol Today 17, 170.
27. 27. SUGITA T., FURUKAWA O., UENO M. et al. (1993) Enhanced expression of interleukin 6 in rat and murine arthritis models. Int J Immunopharmacol 15, 469.
28. 28. OHSHIMA S., SAEKI Y., MIMA T. et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 95, 8222.
29. 29. ANDERTON S.M., VAN DER ZEE R. & GOODACRE J.A. (1993) Inflammation activates self hsp-specific T cells. Eur J Immunol 23, 33.
30. 30. ANDERTON S.M., VAN DER ZEE R., NOORDZU A. et al. (1995) Activation of T cells recognizing self 60-kDa heat shock protein can protect against experimental arthritis. J Exp Med 181, 943.
31. 31. ANDERTON S.M., VAN DER ZEE R., NOORDZU A. & VAN EDEN W. (1994) Differential Mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol 152, 3656.